Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma. (Q54436763)

29 May 2018

title

Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma. (English)

1 reference

29 May 2018

author

John T. Leppert

3

1 reference

29 May 2018

author name string

Tobias Klatte

1

1 reference

29 May 2018

Jinsoo Chung

2

1 reference

29 May 2018

John S Lam

4

1 reference

29 May 2018

Allan J Pantuck

5

1 reference

29 May 2018

Robert A Figlin

6

1 reference

29 May 2018

Arie S Belldegrun

7

1 reference

29 May 2018

publication date

22 January 2007

1 reference

29 May 2018

published in

BJU International

1 reference

29 May 2018

volume

99

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

821-824

1 reference

29 May 2018

Increased incidence of serendipitously discovered renal cell carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (D

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Analysis of the prognostic implications of different tumour margin types in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

Re-evaluation of the Tumour-Node-Metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06729.X

10.1111/J.1464-410X.2006.06729.X

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018